SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques

Authorized vaccines against SARS-CoV-2 remain less available in low- and middle-income countries due to insufficient supply, high costs, and storage requirements. Global immunity could still benefit from new vaccines using widely available, safe adjuvants, such as alum and protein subunits, suited t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalvie, Neil C., Tostanoski, Lisa H., Rodriguez-Aponte, Sergio A., Kaur, Kawaljit, Bajoria, Sakshi, Kumru, Ozan S., Martinot, Amanda J., Chandrashekar, Abishek, McMahan, Katherine, Mercado, Noe B., Yu, Jingyou, Chang, Aiquan, Giffin, Victoria M., Nampanya, Felix, Patel, Shivani, Bowman, Lesley, Naranjo, Christopher A., Yun, Dongsoo, Flinchbaugh, Zach, Pessaint, Laurent, Brown, Renita, Velasco, Jason, Teow, Elyse, Cook, Anthony, Andersen, Hanne, Lewis, Mark G., Camp, Danielle L., Silverman, Judith Maxwell, Nagar, Gaurav S., Rao, Harish D., Lothe, Rakesh R., Chandrasekharan, Rahul, Rajurkar, Meghraj P., Shaligram, Umesh S., Kleanthous, Harry, Joshi, Sangeeta B., Volkin, David B., Biswas, Sumi, Love, J. Christopher, Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926328/
https://www.ncbi.nlm.nih.gov/pubmed/35294244
http://dx.doi.org/10.1126/sciadv.abl6015

Ejemplares similares

Ejemplares similares